Pelvic mass associated with raised CA 125 for benign condition: a case report

<p>Abstract</p> <p>Background</p> <p>Raised CA 125 with associated pelvic mass is highly suggestive of ovarian malignancy, but there are various other benign conditions that can be associated with pelvic mass and a raised CA 125.</p> <p>Case presentation</p> <p>We present a case of 19 year old, Caucasian British woman who presented initially with sudden onset right sided iliac fossa pain and on imaging was found to have 9.8 × 4.5 cm complex cystic mass in right adnexa with a raised CA 125 of 657, which was initially thought to be highly suspicious of cancer but was subsequently found to be due to pelvic inflammatory disease on histology.</p> <p>Conclusion</p> <p>This case highlights the fact that though a pelvic mass with raised CA 125 is highly suggestive of malignancy, pelvic inflammatory disease should always be considered as a differential diagnosis especially in a young patient and a thorough sexual history and screening for pelvic infection should always be carried out in these patients.</p

Trends in support for research and development of cool season food legumes in the developing countries

In addition to their role in human nutrition, food legumes are an integral part of farming systems world wide in diversifying cropping systems and maintaining soil fertility. 1996 world production is around 57 million tonnes. The population in developing countries is expected to be 6.06 billion by 2010, and the demand for food legumes is expected to be around 110.65 million tonnes. This poses a challenge to scientists and policy makers to meet this demand. The growth trends during 1990-94 for area, production, and productivity globally were negative, with few exceptions. Many countries in Asia need to increase production by at least 50% by 2010, and double it by 2020, to meet the needs of the growing population. The current research and development (R&D) thrusts, in developing countries, are geared towards increased production, but with varied success. An increased reliance on plant breeding and extensive cultivation of legumes in marginal areas has led to over-exploitation of the limited genetic resources. Some national governments (eg Turkey and India) have programmes to increase production, but early successes have plateaued, and shifts in direction are needed. The major proportion (50-75%) of R&D funds in developing countries is allocated to staple cereals, and only a small portion of the remaining budget is available for legumes. The following strategies are suggested to strengthen support for food legume research: integrated cropping systems management (variety+agronomic practices+crop rotations) to bridge the yield gap in different agroclimatic conditions; strategic research to breach yield ceilings and develop cultivars that can produce high and stable yields in better-endowed environments and thus compete with cereals; strengthen research collaboration within and among national programmes and with the international agricultural research centres; increase the role of regional, networks and working groups to enhance technical cooperation among developing countries; increase the collaboration between public and private sectors and exploit their comparative advantages to achieve mutual goals; and create Food Legume Councils (that include farmers, traders, and exporters) which support R&D by levying taxes or cesses on commodities and value-added products

Research ethics committees: agents of research policy?

The purpose of this commentary is to describe the unintended effects ethics committees may have on research and to analyse the regulatory and administrative problems of clinical trials. DISCUSSION: The Finnish law makes an arbitrary distinction between medical research and other health research, and the European Union's directive for good clinical trials further differentiates drug trials. The starting point of current rules is that clinical trials are lesser in the interest of patients and society than routine health care. However, commercial interests are not considered unethical. The contrasting procedures in research and normal health care may tempt physicians to continue introducing innovations into practice by relying on unsystematic and uncontrolled observations. Tedious and bureaucratic rules may lead to the disappearance of trials initiated by researchers. Trying to accommodate the special legislative requirements for new drug trials into more complex interventions may result in poor designs with unreliable results and increased costs. Meanwhile, current legal requirements may undermine the morale of ethics committee members. CONCLUSION: The aims and the quality of the work of ethics committees should be evaluated, and a reformulation of the EU directive on good clinical trials is needed. Ethical judgement should consider the specific circumstance of each trial, and ethics committees should not foster poor research for legal reasons

Trends in support for research and development of cool season food legumes in the developing countries

In addition to their role in human nutrition, food legumes are an integral part of farming systems world wide in diversifying cropping systems and maintaining soil fertility. 1996 world production is around 57 million tonnes. The population in developing countries is expected to be 6.06 billion by 2010, and the demand for food legumes is expected to be around 110.65 million tonnes. This poses a challenge to scientists and policy makers to meet this demand. The growth trends during 1990-94 for area, production, and productivity globally were negative, with few exceptions. Many countries in Asia need to increase production by at least 50% by 2010, and double it by 2020, to meet the needs of the growing population. The current research and development (R&D) thrusts, in developing countries, are geared towards increased production, but with varied success. An increased reliance on plant breeding and extensive cultivation of legumes in marginal areas has led to over-exploitation of the limited genetic resources. Some national governments (eg Turkey and India) have programmes to increase production, but early successes have plateaued, and shifts in direction are needed. The major proportion (50-75%) of R&D funds in developing countries is allocated to staple cereals, and only a small portion of the remaining budget is available for legumes. The following strategies are suggested to strengthen support for food legume research: integrated cropping systems management (variety+agronomic practices+crop rotations) to bridge the yield gap in different agroclimatic conditions; strategic research to breach yield ceilings and develop cultivars that can produce high and stable yields in better-endowed environments and thus compete with cereals; strengthen research collaboration within and among national programmes and with the international agricultural research centres; increase the role of regional, networks and working groups to enhance technical cooperation among developing countries; increase the collaboration between public and private sectors and exploit their comparative advantages to achieve mutual goals; and create Food Legume Councils (that include farmers, traders, and exporters) which support R&D by levying taxes or cesses on commodities and value-added products

Clinical Significance of Serum Biomarkers in Pediatric Solid Mediastinal and Abdominal Tumors

Childhood cancer is the leading cause of death by disease among U.S. children between infancy and age 15. Despite successes in treating solid tumors such as Wilms tumor, disappointments in the outcomes of high-risk solid tumors like neuroblastoma have precipitated efforts towards the early and accurate detection of these malignancies. This review summarizes available solid tumor serum biomarkers with a special focus on mediastinal and abdominal cancers in children